GERON CORP Cash Equivalents, at Carrying Value
GERON CORP (GERN) had Cash Equivalents, at Carrying Value of $43.83 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2026-08-05
- 2026-06-30: Cash Equivalents, at Carrying Value $43.83M.
- 2026-03-31: Cash Equivalents, at Carrying Value $48.72M.
- 2025-12-31: Cash Equivalents, at Carrying Value $53.93M.
- 2025-09-30: Cash Equivalents, at Carrying Value $35.23M.
| Period end | Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $43.83M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $48.72M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $53.93M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $35.23M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $38.78M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $55.51M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $50.19M 10-K · filed 2026-03-02 |
| 2024-09-30 | $36.82M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $74.80M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $148.74M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $16.82M 10-K · filed 2025-02-27 |
| 2023-09-30 | $16.52M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $34.42M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $76.46M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $39.77M 10-K · filed 2024-02-28 |
| 2022-09-30 | $51.52M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $69.03M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $27.58M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $31.71M 10-K · filed 2023-03-16 |
| 2021-09-30 | $24.80M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $51.54M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $23.00M 10-Q · filed 2021-05-10 |
| 2020-06-30 | $20.62M 10-Q · filed 2020-08-06 |
| 2019-12-31 | $10.66M 10-K · filed 2021-03-11 |
| 2018-06-30 | $17.14M 10-Q · filed 2018-07-31 |
| 2017-12-31 | $15.02M 10-K · filed 2019-03-07 |
| 2017-06-30 | $4.50M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $12.81M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $11.19M 10-Q · filed 2017-08-09 |
| 2016-09-30 | $5.37M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $5.78M 10-Q · filed 2016-08-03 |
| 2016-03-31 | $10.55M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $19.18M 10-K · filed 2017-03-01 |
| 2015-09-30 | $14.70M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $13.13M 10-Q · filed 2015-08-05 |
| 2015-03-31 | $7.23M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $40.34M 10-K · filed 2016-03-10 |
| 2014-09-30 | $5.45M 10-Q · filed 2014-11-05 |
| 2014-06-30 | $7.31M 10-Q · filed 2014-08-11 |
| 2014-03-31 | $8.83M 10-Q · filed 2014-05-01 |
| 2013-12-31 | $10.29M 10-K · filed 2015-03-11 |
| 2013-09-30 | $6.00M 10-Q · filed 2013-11-07 |
| 2013-06-30 | $5.54M 10-Q · filed 2013-08-08 |
| 2013-03-31 | $12.22M 10-Q · filed 2013-05-03 |
| 2012-12-31 | $18.80M 10-K · filed 2014-03-17 |
| 2012-09-30 | $11.79M 10-Q · filed 2012-11-02 |
| 2011-12-31 | $12.88M 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B |